Myfembree Interactions
There are 645 drugs known to interact with Myfembree (estradiol/norethindrone/relugolix), along with 24 disease interactions, and 8 alcohol/food interactions. Of the total drug interactions, 173 are major, 453 are moderate, and 19 are minor.
- View all 645 medications that may interact with Myfembree
- View Myfembree alcohol/food interactions (8)
- View Myfembree disease interactions (24)
Most frequently checked interactions
View interaction reports for Myfembree (estradiol / norethindrone / relugolix) and the medicines listed below.
- Adderall (amphetamine / dextroamphetamine)
- Adderall XR (amphetamine / dextroamphetamine)
- albuterol
- baclofen
- bupropion
- BuSpar (buspirone)
- buspirone
- cyclobenzaprine
- Cymbalta (duloxetine)
- Flexeril (cyclobenzaprine)
- gabapentin
- hydroxyzine
- ibuprofen
- Lamictal (lamotrigine)
- lamotrigine
- magnesium glycinate
- metformin
- montelukast
- naltrexone
- Nurtec ODT (rimegepant)
- omeprazole
- propranolol
- sertraline
- trazodone
- Ubrelvy (ubrogepant)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Wellbutrin (bupropion)
- Wellbutrin XL (bupropion)
- Zyrtec (cetirizine)
Myfembree alcohol/food interactions
There are 8 alcohol/food interactions with Myfembree (estradiol / norethindrone / relugolix).
Myfembree disease interactions
There are 24 disease interactions with Myfembree (estradiol / norethindrone / relugolix) which include:
- abnormal genital bleeding
- abnormal vaginal bleeding
- carcinomas (estrogenic)
- hypercalcemia in breast cancer
- hypertension
- thromboembolism/cardiovascular
- hepatic neoplasms
- breast malignancy
- liver disease
- thromboembolism
- angioedema
- gallbladder disease
- hypercalcemia
- hyperlipidemia
- liver disease
- melasma
- depression
- fluid retention
- glucose intolerance
- retinal thrombosis
- thyroid function tests
- QT prolongation
- hyperlipidemia
- weight gain
More about Myfembree (estradiol / norethindrone / relugolix)
- Myfembree consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (14)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: sex hormone combinations
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.